Adaptimmune Therapeutics PLC (ADAP) has 156 open-market insider trades by 31 insiders since 2016. The most active filer is Adrian Rawcliffe, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Scott D. Sandell | 10% Owner | — | 5 | $57.6M | 2020-01-24 |
| Anthony A. Florence Jr. | 10% Owner | — | 5 | $57.6M | 2020-01-24 |
| Forest Baskett | 10% Owner | — | 5 | $57.6M | 2020-01-24 |
| David M. Mott | Dir10% Owner | — | 5 | $57.6M | 2020-01-24 |
| Peter W. Sonsini | 10% Owner | — | 5 | $57.6M | 2020-01-24 |
| Ravi Viswanathan | 10% Owner | — | 4 | $52.6M | 2018-09-07 |
| Peter J. Barris | 10% Owner | — | 4 | $49.1M | 2018-09-07 |
| Peter J. Barris | 10% | — | 4 | $49.1M | 2018-09-07 |
| Peter A. Thompson | Dir | — | 6 | $43.0M | 2018-06-06 |
| Patrick J. Kerins | 10% Owner | — | 4 | $32.5M | 2018-09-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Gavin Wood | CFO | Sell | $960 | 2025-09-02 |
| William C. Bertrand Jr. | COO | Sell | $2K | 2025-08-28 |
| Ali Behbahani | Director | Sell | $342K | 2025-08-15 |
| EcoR1 Capital, LLC | 10% Owner | Sell | $13.2M | 2025-07-28 |
| William C. Bertrand Jr. | COO | Sell | $3K | 2025-01-17 |
| Adrian Rawcliffe | CEO | Sell | $18K | 2025-01-17 |
Companies that share insiders with ADAP, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Cintia Piccina | Chief Commercial Officer | Sell | $7K | 2025-01-15 |
| Elliot Norry | Chief Medical Officer | Sell | $13K | 2025-01-13 |
| John Lunger | Chief Patient Supply Officer | Sell | $11K | 2025-01-13 |
| Adrian Rawcliffe | CEO | Sell | $35K | 2025-01-13 |
| Cintia Piccina | Chief Commercial Officer | Sell | $23K | 2024-06-18 |
| John Lunger | Chief Patient Supply Officer | Sell | $16K | 2024-01-16 |
| Adrian Rawcliffe | CEO | Sell | $28K | 2024-01-16 |
| William C. Bertrand Jr. | COO | Sell | $16K | 2024-01-16 |
| Elliot Norry | Chief Medical Officer | Sell | $14K | 2024-01-16 |